Trade Summary

6 days ago, Wahlstrom Mats, serving as Dir at Trisalus Life Sciences, Inc. (TLSI), purchased 60,000 shares at $2.53 per share, for a total transaction value of $151,800.00. Following this transaction, Wahlstrom Mats now holds 2,962,030 shares of TLSI.

This purchase represents a 2.00% increase in Wahlstrom Mats's stake in the company. This is considered a medium-conviction trade.

The trade was executed on Friday, May 15, 2026 and publicly disclosed via SEC Form 4 filing on Monday, May 18, 2026 at 4:42 PM ET, 3 days after the trade was made.

Trisalus Life Sciences, Inc. operates in the HEALTHCARE sector, specifically within the MEDICAL DEVICES industry. Insider buying activity in this sector can provide valuable signals about industry trends and company-specific developments.